FDA Action Alert: Karyopharm, Merck and Celgene

FDA Action Alert: Karyopharm, Merck and Celgene

Source: 
BioSpace
snippet: 

The month of July is a slow one for the U.S. Food and Drug Administration (FDA), at least in terms of scheduled approval dates. Here’s a look at the three PDUFA dates the agency has on its calendar for the month.